Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $106.25 | Total: $531.25 |
| 1 | 10 | $90.00 | Total: $900.00 |
| 1 | 25 | $76.25 | Total: $1,906.25 |
| 1 | 50 | $65.00 | Total: $3,250.00 |
| 1 | 100 | $56.25 | Total: $5,625.00 |
Overview
MA-0204 is a highly selective and orally available peroxisome proliferator-activated receptor ? (PPAR?) modulator (EC50s: 0.4 nM, 7.9 nM and 10 nM for human, mouse and rat PPAR?, respectively). It is a potential treatment for Duchene Muscular Dystrophy (DMD).
Chemical Properties
| Molecular Formula | C25H27F3N2O4 |
| Molecular Weight | 476.49 |
| CAS Numbers | 2095128-17-7 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C[C@H](CCCOc1ccccc1Cn1c(C)cnc1-c1ccc(OC(F)(F)F)cc1)CC(O)=O |
Storage and Handling
0C Short Term, -20C Long Term
References
Lagu B, et al. Selective PPAR? Modulators Improve Mitochondrial Function Potential Treatment for Duchenne Muscular Dystrophy [DMD]. ACS Med Chem Lett. 2018 Jul 31;9[9] 935-940.